%PDF-1.6
%
1 0 obj
<>stream
2020-09-12T04:32:28+05:30
2020-10-07T03:20:06-07:00
2020-10-07T03:20:06-07:00
Acrobat Distiller 10.1.7 (Windows)
10.1111/bjh.17093
10.1111/(ISSN)1365-2141
3
VoR
10.1111/bjh.17093
application/pdf
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL‐class fusion
uuid:5be1d7f0-048c-4180-a6a8-063678063f6b
uuid:27e9a450-905c-4308-9623-256565353880
Acrobat Distiller 10.1.16 (Windows); modified using iText 4.2.0 by 1T3XT
endstream
endobj
4 0 obj
<>stream
hޔ[rH}GLe6 F
JvҖY= ogGl
融hu̪r4?5v_GOzhi?ջjvR9;sij4t)ژ"46vg9ӱ
uQRaѨ˛Wo
-ysws1Bv$v-z~ >]WV|;_q|(Bdu+|Ӟq#\0
lB|~3&8YҙR6LˈXAb~ή:l`.KM-NxRA}Ǽ,\iL9%xۼ79g.f;^iiBՊ)(^UwᅧtW+JZٷ8}\\d)5ΜCct,2'dT9&ӗhw|HVdyEBObC"lvSV}8]j$Ɍ mbҞ%$hZ?2$4Izz_ݟJeN(rZL8*jF6:y-O\hRH.UK^ʼk%&-yJgMDƬOwMwwQpz_$F&i+Զ0Ilf&"VQp_gbF-[zDdySh܃L1c~/)(V+jQV4QD)EbwԒ!^]ͪ(*
|#X?5ۼyU?k;%@Woc .˘uW!ER\.DCPaZ~$q#
F\a3p@t \ըZ&'o+\`eǛ,|]7Mj`Fղ_h[f@u$BL_ZS]4Yr
7H9K &E,BK\*5~w.07w--A}*k^#kqȈ3Ϋv@qlPI}B˼6(Lǀ1{H%z?^"61'_`esyoE+EHn~0_oLt.21/n;<
9ݜ$<출97G M\HeHѬ's$%
&]ni͜)Xɂ~o+ya^k0Ѽ+aJu.@c
xJsJrcOrE)"DbM]!,8+.x,o7Z1U"V|V_5aX|Uv2ǸmS<$&ej$ŦS~{%3d͂ %욾ECUQqBw s[?S㎘Y@6D|I)f:ra35∋>"=|}4Ea'N8BN +2rŜ,Gp)@~{!JGnaihޏ'Y .d=(fB.BTާ{sa
hfE!] 5vG9Mxo?x
,Yp4jA#g=,Oӆ}D#s;s^`PBV,F|zd[%1cwizl&;8:8fcHo}YF`c-dCsո7}F@^G/A,#
R<{.?m))쓡HkBGq)hNƩԻ OVAN"/gT-9*
tJj")I|d$x;k%N4}(gB\:[d
z3ZY